Inebilizumab
Catalogue number:
HY-P99113-1mg
Supplier:
Size:
1 mg
Product is available in:
Applications:
COVID-19-immunoregulation
Target:
ADC Antibody;CD19
Alternative Names:
MEDI-551
- Data sheet: View or download
- MSDS: View or download
- Protocol: View or download
Product Description:
Inebilizumab is an anti-CD19 monoclonal antibody (mAb) with enhanced antibody-dependent cell-mediated cytotoxicity against B cells. Inebilizumab can be used for multiple sclerosis and neuromyelitis optica research[1].